Cartherics is a biotechnology company focused on innovating immunotherapy treatments for solid cancers. By redefining immune targeting through advanced gene-based approaches, Cartherics aims to provide more precise and accessible alternatives for patients, enhancing their immune systems to effectively combat various cancer types.